264 related articles for article (PubMed ID: 9454806)
1. Fenfluramine and norfenfluramine levels in brain microdialysate, brain tissue and plasma of rats administered doses of d-fenfluramine known to deplete 5-hydroxytryptamine levels in brain.
Clausing P; Newport GD; Bowyer JF
J Pharmacol Exp Ther; 1998 Feb; 284(2):618-24. PubMed ID: 9454806
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels of parent compound and metabolites after doses of either d-fenfluramine or d-3,4-methylenedioxymethamphetamine (MDMA) that produce long-term serotonergic alterations.
Bowyer JF; Young JF; Slikker W; Itzak Y; Mayorga AJ; Newport GD; Ali SF; Frederick DL; Paule MG
Neurotoxicology; 2003 Jun; 24(3):379-90. PubMed ID: 12782103
[TBL] [Abstract][Full Text] [Related]
3. Effects of antihistamines on fenfluramine-induced depletion of indoles in the brain of rats.
Yeh SY
Synapse; 1999 Jun; 32(4):301-11. PubMed ID: 10332805
[TBL] [Abstract][Full Text] [Related]
4. High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrain.
Rothman RB; Jayanthi S; Wang X; Dersch CM; Cadet JL; Prisinzano T; Rice KC; Baumann MH
Synapse; 2003 Dec; 50(3):233-9. PubMed ID: 14515341
[TBL] [Abstract][Full Text] [Related]
5. In vivo correlates of central serotonin function after high-dose fenfluramine administration.
Baumann MH; Ayestas MA; Rothman RB
Ann N Y Acad Sci; 1998 May; 844():138-52. PubMed ID: 9668672
[TBL] [Abstract][Full Text] [Related]
6. Effects of repeated fenfluramine administration on indices of monoamine function in rat brain: pharmacokinetic, dose response, regional specificity and time course data.
Zaczek R; Battaglia G; Culp S; Appel NM; Contrera JF; De Souza EB
J Pharmacol Exp Ther; 1990 Apr; 253(1):104-12. PubMed ID: 2329498
[TBL] [Abstract][Full Text] [Related]
7. Elevated environmental temperatures can induce hyperthermia during d-fenfluramine exposure and enhance 5-hydroxytryptamine (5-HT) depletion in the brain.
Stewart CW; Bowyer JF; Slikker W
J Pharmacol Exp Ther; 1997 Dec; 283(3):1144-50. PubMed ID: 9399987
[TBL] [Abstract][Full Text] [Related]
8. Clinical-pharmacological study with the two isomers (d-, l-) of fenfluramine and its comparison with chlorpromazine and d-amphetamine: blood levels, EEG mapping and safety evaluation.
Saletu B; Barbanoj MJ; Anderer P; Sieghart W; Grünberger J
Methods Find Exp Clin Pharmacol; 1993 Jun; 15(5):291-312. PubMed ID: 8412414
[TBL] [Abstract][Full Text] [Related]
9. Amphetamine levels in brain microdialysate, caudate/putamen, substantia nigra and plasma after dosage that produces either behavioral or neurotoxic effects.
Clausing P; Gough B; Holson RR; Slikker W; Bowyer JF
J Pharmacol Exp Ther; 1995 Aug; 274(2):614-21. PubMed ID: 7636721
[TBL] [Abstract][Full Text] [Related]
10. Fenfluramine and 5-hydroxytryptamine. Part 2: Involvement of brain 5-hydroxytryptamine in the anorectic activity of fenfluramine.
Duhault J; Boulanger M; Voisin C; Malen C; Schmitt H
Arzneimittelforschung; 1975 Nov; 25(11):1758-62. PubMed ID: 128366
[TBL] [Abstract][Full Text] [Related]
11. Substituted amphetamines that produce long-term serotonin depletion in rat brain ("neurotoxicity") do not decrease serotonin transporter protein expression.
Rothman RB; Jayanthi S; Cadet JL; Wang X; Dersch CM; Baumann MH
Ann N Y Acad Sci; 2004 Oct; 1025():151-61. PubMed ID: 15542713
[TBL] [Abstract][Full Text] [Related]
12. Determination of D-fenfluramine, D-norfenfluramine and fluoxetine in plasma, brain tissue and brain microdialysate using high-performance liquid chromatography after precolumn derivatization with dansyl chloride.
Clausing P; Rushing LG; Newport GD; Bowyer JF
J Chromatogr B Biomed Sci Appl; 1997 May; 692(2):419-26. PubMed ID: 9188832
[TBL] [Abstract][Full Text] [Related]
13. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
14. Administration of fenfluramine at different ambient temperatures produces different core temperature and 5-HT neurotoxicity profiles.
Malberg JE; Seiden LS
Brain Res; 1997 Aug; 765(1):101-7. PubMed ID: 9310399
[TBL] [Abstract][Full Text] [Related]
15. Acute effects of dexfenfluramine (d-FEN) and methylenedioxymethamphetamine (MDMA) before and after short-course, high-dose treatment.
Frederick DL; Ali SF; Gillam MP; Gossett J; Slikker W; Paule MG
Ann N Y Acad Sci; 1998 May; 844():183-90. PubMed ID: 9668676
[TBL] [Abstract][Full Text] [Related]
16. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
Wang X; Baumann MH; Xu H; Rothman RB
Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
[TBL] [Abstract][Full Text] [Related]
17. The role of d-norfenfluramine in the indole-depleting effect of d-fenfluramine in the rat.
Caccia S; Anelli M; Ferrarese A; Fracasso C; Garattini S
Eur J Pharmacol; 1993 Mar; 233(1):71-7. PubMed ID: 7682511
[TBL] [Abstract][Full Text] [Related]
18. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
McNamara R; Kerans A; O'Neill B; Harkin A
Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
[TBL] [Abstract][Full Text] [Related]
19. Is receptor activation involved in the mechanism by which (+)-fenfluramine and (+)-norfenfluramine deplete 5-hydroxytryptamine in the rat brain?
Invernizzi R; Kmieciak-Kolada K; Samanin R
Br J Pharmacol; 1982 Mar; 75(3):525-30. PubMed ID: 6175368
[TBL] [Abstract][Full Text] [Related]
20. Fenfluramine and 5-hydroxytryptamine?. Part 1: Is fenfluramine or norfenfluramine involved in the decrease of brain 5-hydroxytryptamine.
Duhault J; Malen C; Boulanger M; Voisin C; Beregi L; Schmitt H
Arzneimittelforschung; 1975 Nov; 25(11):1755-8. PubMed ID: 1243082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
